General Information of Drug (ID: DMXVCL0)

Drug Name
2-(2-methoxyphenyl)-6-morpholino-4H-pyran-4-one
Synonyms CHEMBL105256; 2-(2-methoxyphenyl)-6-morpholino-4H-pyran-4-one; SCHEMBL3538816; BDBM50132363; 2-Morpholino-6-(2-methoxyphenyl)-4H-pyran-4-one
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
#Ro5 Violations (Lipinski): 0 Molecular Weight (mw) 287.31
Logarithm of the Partition Coefficient (xlogp) 1.7
Rotatable Bond Count (rotbonds) 3
Hydrogen Bond Donor Count (hbonddonor) 0
Hydrogen Bond Acceptor Count (hbondacc) 5
Chemical Identifiers
Formula
C16H17NO4
IUPAC Name
2-(2-methoxyphenyl)-6-morpholin-4-ylpyran-4-one
Canonical SMILES
COC1=CC=CC=C1C2=CC(=O)C=C(O2)N3CCOCC3
InChI
InChI=1S/C16H17NO4/c1-19-14-5-3-2-4-13(14)15-10-12(18)11-16(21-15)17-6-8-20-9-7-17/h2-5,10-11H,6-9H2,1H3
InChIKey
ZDNMYLJFYAXNHH-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
21106400
CAS Number
155906-26-6
TTD ID
D02DDM

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
DNA-dependent protein kinase catalytic (PRKDC) TTK3PY9 PRKDC_HUMAN Inhibitor [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 Pyranone, thiopyranone, and pyridone inhibitors of phosphatidylinositol 3-kinase related kinases. Structure-activity relationships for DNA-dependen... J Med Chem. 2007 Apr 19;50(8):1958-72.